RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing ...

New research has revealed that a hairy crustacean—dubbed "The Hoff crab" when it was discovered in 2010—is the first species ...

RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath®, a novel, FDA-cleared delivery platform, today ...

United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

Children’s Hospital Los Angeles Cardiology chief Paul F Kantor said: “It’s a commitment we take seriously as one of the top pediatric cardiology and heart surgery programmes ...

MOUNTAIN VIEW, Calif. - RenovoRx , Inc. (NASDAQ:RNXT), a $35.7 million market cap developer of targeted oncology therapies, has initiated an underwritten public offering of its common stock and ...

CENTRAL TRUST Co lifted its stake in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 162.2% in the 4th quarter, ...

P.M.,’ continues the intense day-long shift of Robby’s emergency team at Pittsburgh Trauma Medical Center. While the show has felt overwhelming from the start, the sixth episode pushes the senior ...

The hormone triggers insulin resistance in blood vessel endothelium in obesityA large proportion of the approximately six ...